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Background: Tissue microenvironments comprise different extracellular matrix (ECM) proteins that regulate cellular
responsiveness to growth factors. In vitro culture of adherent cells on ECM-coated substrata is commonly used to
study microenvironmental influence on specific cell signaling responses. Phosphorylation-specific flow cytometry
can be utilized to quantify intracellular phosphorylation-dependent signaling events in single cells. However this
approach necessitates trypsinization of adherent cells to accommodate flow cytometric analysis. Trypsin is a potent
activator of cell signaling and can obscure signal transduction events induced by other factors.
Results: To address this we developed a cold trypsin-phosphorylation-specific flow cytometry protocol, where
adherent cells are prepared for flow cytometric analysis on ice (~0°C), a temperature where trypsin retains activity
but where intracellular kinases are inactive. We show that this straightforward approach can be used to quantify
intracellular pERK levels in single adherent primary human vascular smooth muscle cells grown on different ECM.
Conclusions: Exploiting the limited temperature dependence of trypsin facilitated development of a generally
applicable phosphorylation-specific flow cytometry method for analysis of adherent cell types including primary
patient derived cells. We demonstrate the utility of cold trypsin-phosphorylation-specific flow cytometry analysis of
cell signaling to measure microenvironmental influence in single adherent cells.
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The signaling pathways that drive different normal and
pathological cellular responses are controlled by microen-
vironmental cues, including cell-cell interactions, ECM-
integrin engagement and activation of receptor tyrosine
kinases by growth factors. This intracellular signal
transduction creates unique response-dependent epitopes
that can be detected by specific antibodies providing the
opportunity to measure signaling events by various
immuno-techniques. Phosphorylation-specific flow cytom-
etry enables measurement of the phosphorylation status of
multiple intracellular signaling proteins at a single-cell
level [1-3]. However, the laminar fluidic flow systems of
standard flow cytometers require that cells are in suspen-
sion and a near-spherical configuration for effective* Correspondence: jim.lorens@biomed.uib.no
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distribution, and reproduction in any mediumanalysis. To allow the adaptation of phosphorylation-
specific flow cytometry approach to study primary adher-
ent human cells, we took advantage of the broad
temperature-independent activity of trypsin to allow pro-
teolytic release of single adherent cells at low tempera-
tures. We show that cold-trypsin phosphorylation-specific
flow cytometry analysis can be used to quantify phosphor-
ylated ERK (pERK) levels in single human pulmonary
artery-derived smooth muscle cells (PaSMC) exposed to
different ECM proteins.
Methods
Cold trypsin phosphorylation-specific flow cytometry
analysis of adherent cells
Low passage (<10) PaSMCs (Lonza, Cologne, Germany)
were grown at 37°C, 5% CO2 in human fibroblast growth
factor (hFGF)-supplemented smooth muscle growth
medium-2 (SmGM-2; Lonza, Cologne, Germany) on
ECM protein coated tissue culture plates until abouted Central Ltd. This is an Open Access article distributed under the terms of
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passive adsorption with collagen I (0.1 mg/ml), fibronec-
tin (15 μg/ml) and laminin (15 μg/ml) (Sigma-Aldrich,
St. Louis, MO, USA). PaSMC were serum starved over-
night prior to stimulation with 50 nM phorbol-12-myris-
tate-13-acetate (PMA; Sigma-Aldrich, St. Louis, MO,
USA) for 5 minutes or 20% fetal bovine serum (FBS;
PAA Laboratories, Pasching, Austria) for 15 minutes.
The cells were placed on ice immediately after sti-
mulation to quench cell signaling. The cells were then
washed twice with ice cold phosphate buffered saline
(PBS; Sigma-Aldrich) before adding ice cold 0.5% Trypsin-
Ethylenediaminetetraacetic acid (EDTA; Sigma-Aldrich).
Culture plates were kept on ice and monitored by mi-
croscopy until the cells had completely rounded up and
detached from the cell culture dish (approximately
25 minutes). Alternatively, cells were detached with
0.25% Trypsin-EDTA at 37°C for 2 minutes. A 16%
paraformaldehyde (PFA) solution (Electron Microscopy
Sciences, Hatfield, PA, USA) was added directly to the
single cell suspension to obtain a final concentration of
1.6% PFA. The cells were incubated in the fixative for
20 minutes at room temperature. The cells were there-
after washed with ice cold PBS and pelleted before they
were permeabilized in 100% ice-cold methanol (Sigma-
Aldrich) overnight at 4°C [2,3]. To stain the cells for
flow cytometry, the samples were first centrifuged at
500 × g for 5 minutes to remove the methanol and then
washed with FACS buffer (1% BSA in PBS). Cells were
then stained with rabbit anti-p44/42 MAPK (ERK1/2)
antibody (#4695 Cell Signaling, Danvers, MA, USA) at
a dilution of 1:1000 for 30 minutes at room tem-
perature. The cell suspension was then washed with
FACS buffer before goat anti-rabbit IgG-Alexa Fluor
647 (A-21244, Invitrogen; Life Technologies, Grand
Island, NY, USA) was added at a concentration
of 1:2500 (0.8 μg/mL) as a secondary antibody. The
cells were incubated for 1 hour in darkness at room tem-
perature before being washed once more with FACS buffer.
Samples were run on a BD Accuri C6 (BD Biosciences, San
Jose, CA, USA) equipped with 488 nm and 640 nm lasers
at the University of Bergen Flow Cytometry Core Facility.
Daily quality control is performed on the instrument using
8- and 6- peak bead sets. The standard bandpass filter used
for Alexa Fluor 647: 675/25 Alexa fluor 647 (excitation
max: 640 nm, emission max: 668 nm). A minimum of
10,000 events was collected for each sample. The gating
strategy comprised a standard FSC/SSC live cell gate,
followed by a FSC-A/FSC-H single cell gate to minimize
inclusion of debris, dead cells and aggregates in the analysis
of Alexa Fluor 647 fluorescence. Alternatively fixable live/
dead dyes may be added to prior to PFA treatment to en-
hance discrimination of dead cells in the analysis. Flow
data analysis and median fluorescence intensity (MFI)calculations were performed using FlowJo (TreeStar Inc.,
Ashland, OR, USA). All fluorescence values were cor-
rected by subtracting the MFI value of the secondary
only goat anti-rabbit IgG-Alexa Fluor 647 staining. Cell
viability of trypsinization protocols was evaluated by
propidium iodide exclusion (1 ug/ml for 5 minutes,
room temperature) and flow cytometry analysis (BD
FACS Aria II, 532 nm laser; 610/20 BP filter). No differ-
ence in the percentage of dead cells within the PI-
positive gate (<3%) was observed following either warm
or cold trypsinization of PaSMC.
Western blot analysis
PaSMC were grown in ECM protein coated 10 cm cell
culture plates until 80% confluence, serum starved and
treated with 50 nM PMA for 5 minutes or 20% FBS for
15 minutes at 37°C, 5% CO2. After stimulation the cells
were washed twice with ice cold PBS before 300 μL ice-
cold Nonidet-P40 (NP40) lysis buffer was added and
cells were scraped off the dish using a cell scraper and
transferred to an eppendorf tube and kept on ice for
20 minutes. The samples were sonicated 3 times for
10 seconds and then centrifuged at 16,000 × g for 5 -
minutes at 4°C. Supernatants were transferred to a fresh
tube and stored at −20°C. The protein concentration was
then determined by BCA Protein Assay Kit (Thermo
Fisher Scientific, Waltham, MA, USA). XT Sample buf-
fer (Bio Rad, Hercules, CA, USA) was added to the
samples and heated at 95°C for 10 minutes, cooled
down and loaded onto NuPAGE 10% Bis-Tris gels
(Invitrogen, Carlsbad, CA, USA), and run for 50 mi-
nutes at 200 Volts in NuPAGE MOPS SDS Running
Buffer (Invitrogen). Proteins were transferred to a
polyvinylidene fluoride (PVDF) transfer membrane (GE
Healthcare, Little Chalfont, Buckinghamshire, UK) for
1 hour at 100 Volts. The membrane was blocked in
TBS/T (0.1% Tween 20) with 5% (weight/volume) dried
skimmed milk powder. After blocking, the membrane
was washed 4 times for 5 minutes in TBS/T. The mem-
brane was then incubated with anti-pERK primary anti-
body (p44/42 MAPK antibody 4695; Cell Signaling) at
a dilution of 1:2000. The primary antibody was added
in TBS/T with 5% (w/v) BSA and incubated over night
at 4°C. The membrane was then washed 4 times
for 5 minutes in TBS/T before staining with Goat Anti-
Rabbit IgG (H+L)-HRP Conjugate 170–6515 (Bio-Rad)
secondary antibody at a dilution of 1:10,000. The mem-
brane was incubated with secondary antibody in TBS/T
with 5% (w/v) dried skimmed milk powder for 1 hour
at room temperature before being washed again, 4 times
for 5 minutes with TBS/T. Loading control was performed
using monoclonal mouse Anti-Human Smooth Muscle
Actin Clone 1A4 (Dako, Glostrup, Denmark) with Goat
Anti-Mouse IgG (H+L)-HRP Conjugate 170–6516
Figure 1 Schematic of the cold trypsin phosphorylation-specific
flow cytometry approach. Cells grown on cell culture dishes at
37°C are treated with activators for the required time and then
immediately placed on ice to quench further cell signaling. Ice cold
trypsin is added to the cell culture plates and kept on ice during the
trypsinization process in order to minimize intracellular signaling.
The cells are then harvested, fixed and permeablized prior to
staining with optimized phospho-specific primary antibodies and
fluorophore-conjugated secondary reagents. Stained cells are
analyzed by flow cytometry to quantify single cell fluorescence
values corresponding to phosphorylated levels of intracellular
signaling proteins.
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veloped in a Chemi Doc XRS (Bio Rad) using Pierce ECL
Western Blotting substrate (Thermo Fisher Scientific).
Quantification of Western blot bands was conducted using
the ImageLab 3.0 software (BioRad). Mean pixel intensity
was measured for each band, background was subtracted
and samples were normalized to beta-actin.
Results and discussion
Quantifying pERK in single adherent cells by
phosphorylation-specific flow cytometry
Flow cytometry of adherent cells is routinely carried out
by first detaching cells from tissue culture dishes or dis-
sociating intact tissues by treating with the serine prote-
ase trypsin. Trypsin is known to activate cell signaling
via the protease-activator receptor 2 (PAR2), a seven
transmembrane-spanning domain G protein-coupled re-
ceptor, by cleaving the amino-terminal exodomain [4].
PAR2 activation stimulates MAP kinase pathway activity
in epithelial and smooth muscle cells [5,6]. Trypsin acti-
vation of PAR2 is also shown to activate MAP phosphat-
ase activity and attenuate pERK level induction by other
receptors [6,7]. Hence, trypsin can lead to both potenti-
ated and attenuated pERK levels induced by other
receptors.
We reasoned that adherent cells could be prepared for
phosphorylation-specific flow cytometry using a cold tryp-
sin solution (Figure 1). Trypsin remains nearly 50% active
at 4°C, a temperature where intracellular kinases lack activ-
ity [8]. Trypsinization of PaSMC on ice (~0°C) did not ad-
versely affect cell viability (data not shown), consistent with
a previous report [9]. Semiconfluent low passage PaSMC
cultures were stimulated with PMA at 50 nM for 5 minutes,
or with 20% FBS for 15 minutes and prepared for
phosphorylation-specific flow cytometry analysis by
trypsinization at 37°C or on ice. Cells were kept on ice dur-
ing the cold trypsin protocol in order to quench cell signal-
ing. PaSMC detached within 25 minutes on ice and within
approximately 2 minutes at 37°C. Detached PaSMC were
collected, fixed with paraformaldehyde, permeabilized with
methanol and stained with anti-pERK1/2 (phospho-
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analyzed by flow cytometry to determine pERK levels. In
preliminary experiments we noted variation in pERK
levels following trypsinization at 37°C in unstimulated cell
cultures, while basal pERK levels remained low following
trypsinization at on ice (data not shown). This is in part
due to the rapid detachment of PaSMC at 37°C. As shown
in Figure 2, PaSMC treated with 50 nM PMA and recov-
ered by trypsin treatment at 37°C showed a 1.6-fold in-
crease in pERK (MFI=14210) as compared to the
unstimulated cells (MFI=8844). In contrast, pERK levels in
cells recovered by cold trypsin showed a 3.6-fold increaseFigure 2 pERK levels are affected by post-treatment trypsinization at
50 nM for 5 minutes or 20% FBS for 15 minutes at 37°C, 5% CO2 and prepa
trypsinization at 37°C or 0°C. Cells were pretreated with the MEK1 inhibitor
cytometry analysis of pERK levels in PMA- and serum-treated PaSMC. Rabbi
quantified (10,000 events) and plotted as overlaid histograms of fluorescen
measured for PMA- and serum-induced pERK levels following post-treatme
the basal pERK levels and attenuated the activation of pERK by PMA. Contr
three independent experiments).following treatment with PMA (unstimulated, MFI=6806;
PMA treated, MFI=24341). Relative pERK activation was
1.5-fold increase by 20% FBS treatment when trypsinized
at 37°C (unstimulated, MFI=8844; serum treated,
MFI=13678) and 1.7-fold increase by 20% FBS treatment
with cold trypsin (unstimulated, MFI=6806; serum treated,
MFI=11713). In order to verify the specificity of the anti-
phosphorylated ERK signal detected by phosphorylation-
specific flow cytometry, cells were pretreated with an in-
hibitor of the upstream MAP kinase MEK1 (PD98059) at
30 μM for 3 hours. Pretreatment with PD98059 inhibited
pERK activation in PaSMCs stimulated with PMA ordifferent temperatures. PaSMC cultures were stimulated with PMA
red for phosphorylation-specific flow cytometry analysis by
PD98059 at 30 μM for 3 hours to inhibit pERK activation. A: Flow
t anti-pERK/goat-anti-rabbit-Alexa Fluor 647 secondary antibody was
ce versus number of cells. B: Median fluorescence intensity (MFI)
nt trypsinization at 37°C or 0°C. Trypsinization at 37°C both increased
ol: Goat-anti-rabbit Alexa Fluor 647 secondary only. (Representative of
Figure 3 PaSMC adherence to extracellular matrix regulates the MAP kinase pathway. Semiconfluent PaSMC cultured on collagen I,
fibronectin and laminin and analyzed by Western blot or cold trypsin phosphorylation-specific flow cytometry to measure changes in pERK
following stimulation with PMA and serum. A: Western blot analysis of pERK1/2 levels in PaSMC lysates from PMA and serum treated cells
cultured on collagen I, fibronectin and laminin. Anti-smooth muscle actin is shown as a loading control. Normalized mean pixel intensity values
for the pERK1/2 bands are indicated. B: Analysis of anti-pERK levels by cold trypsin phosphorylation-specific flow cytometry of PMA and serum
treated PaSMC cultured on uncoated and collagen I, fibronectin and laminin-coated plates revealed a uniform increases in pERK activation.
Plotted as overlaid histograms of fluorescence versus number of cells. C: Median fluorescence intensity (MFI) of anti-pERK levels determined by
cold trypsin phosphorylation-specific flow cytometry of PMA and serum treated PaSMC cultured on collagen I, fibronectin and laminin.
D: Plot of MFI values normalized to unstimulated PaSMC cultures on uncoated and collagen I, fibronectin and laminin-coated plates. Control:
Goat-anti-rabbit Alexa Fluor 647 secondary only. (Representative of three independent experiments).
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dicate that the cold trypsin phosphorylation-specific flow
cytometry protocol is a preferable approach to measure
cell signaling changes in adherent cells.
Activation of the MAP kinase pathway is regulated
by ECM
Vascular smooth muscle cells (vSMC) are normally
surrounded by a laminin-rich basal lamina. During homeo-
static or pathological vascular remodeling, vSMCs areexposed to dynamic changes in the local ECM, including
loss of basement membrane and synthesis of new ECM
components such as fibronectin, that can lead to vSMC
proliferation, a major contributor to restenosis, vein graft
thickening and atherosclerosis [10-12]. The laminin-rich
basal lamina suppresses growth and promotes vSMC differ-
entiation, while fibronectin transitional matrix deposited
during vascular remodeling stimulate growth [13].
To address the effect of different ECM proteins on
MAP kinase signaling in vSMC, we cultured PaSMCs
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nectin or laminin with growth factor (FGF) and
serum supplemented culture medium. Semiconfluent
PaSMC cultures were starved overnight and stimu-
lated with PMA or serum. Western blot analysis of
PaSMC lysates (Figure 3A) showed relative increases
in both pERK1/2 bands at 42 and 44 kDa, following
treatment with PMA or serum. In order to quantify
these ECM-induced changes in MAP kinase path-
way activation, we conducted the cold trypsin
phosphorylation-specific flow cytometry analysis to
measure pERK levels. Histogram plots of the anti-
pERK fluorescence (Figure 3B) revealed a uniform in-
crease in pERK activation in PMA and serum treated
PaSMCs cultured on different ECM. Basal pERK
levels in PaSMCs cultured on laminin were 2.8 and
2.5 fold less than PaSMC cultured on collagen
I or fibronectin respectively (Figure 3C). Treatment
with PMA or serum strongly activated pERK under
all conditions. Compared to unstimulated cells (MFI=
3576), pERK levels in cells cultured on tissue culture
dishes with no coating were upregulated 6.3 and 2.3
fold when treated with PMA (MFI=23700) and serum
(MFI=8808) respectively. For cells growing on colla-
gen I, treatment with PMA and serum upregulated
pERK levels 6.7 and 2.3 fold (unstimulated, MFI=4733;
PMA treated, MFI=31758; serum treated, MFI=10906).
Cells on fibronectin were upregulated 5.1 and 1.8 fold
when treated with PMA and serum respectively (un-
stimulated, MFI=4249; PMA treated, MFI=21739;
serum treated, MFI=7771), while in cells grown on
laminin-coated dishes the upregulation of pERK levels
were 10.6 and 2.3 fold when treated with PMA
(MFI=17690) or serum (MFI=3775) compared to the
unstimulated cells (MFI=1668). PaSMC cells cultured
on collagen and fibronectin display a nearly identical
pERK response profile to that of cells cultured on un-
coated plates when normalized against unstimulated
cells, while cells cultured on laminin displayed an in-
creased relative pERK responsiveness to PMA stimulation
(Figure 3D).
Conclusions
Exploiting the limited temperature dependence of tryp-
sin facilitated development of a generally applicable
phosphorylation-specific flow cytometry method facilitat-
ing cell signaling analysis in adherent cell types includ-
ing primary patient derived cells. We demonstrate the
utility of cold trypsin-phosphorylation-specific flow cy-
tometry analysis of cell signaling to measure ECM influ-
ence in single adherent vSMC. Our results indicate that
vSMC adherence to laminin reduces basal pERK levels
consistent with suppressed growth, but maintain respon-
siveness to serum and PKC-dependent signaling.Flow cytometry analysis offers an attractive alter-
native to other approaches to multiparametric meas-
urement of phosphorylation-dependent cell signaling
events in adherent cells at single cell resolution, such
as fluorescence scanning of arrayed cells or high con-
tent microscopy-based systems [14]. In particular,
phosphorylation-specific flow cytometry offers super-
ior quantification of phospho-epitopes detected by
immunofluorescence [2,3]. As this sensitivity is
achieved at the expense of cell morphological infor-
mation, an integration of complementary flow cytom-
etry and microscopy approaches is optimal.
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